Inventor
RAHBAR SAMUEL
US17 patents
⚠️ This page may combine multiple inventors who share the name “RAHBAR SAMUEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
14 patentsUS6605642B2Aug 12, 2003
Inhibitors of formation of advanced glycation endproducts (AGES)
HOPE CITY23 citations92
US6589944B1Jul 8, 2003
Breakers of advanced glycation endproducts
HOPE CITY28 citations92
US6337350B1Jan 8, 2002
Inhibitors of formation of advanced glycation endproducts (AGEs)
HOPE CITY47 citations92
US6787566B2Sep 7, 2004
Breakers of advanced glycation endproducts
HOPE CITY14 citations83
US6693106B2Feb 17, 2004
Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)
HOPE CITY15 citations83
US7652037B2Jan 26, 2010
Methods of lowering lipid levels in a mammal
HOPE CITY8 citations81
US7320988B2Jan 22, 2008
Methods of lowering lipid levels in a mammal
HOPE CITY10 citations81
US7030133B2Apr 18, 2006
Inhibitors of formation of advanced glycation endproducts (AGEs)
HOPE CITY8 citations73
US11583509B2Feb 21, 2023
Compound for treating cancer and diabetes
HOPE CITY0 citations57
US11266618B2Mar 8, 2022
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG
HOPE CITY0 citations52
US11179361B2Nov 23, 2021
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG
HOPE CITY0 citations52
US10029991B2Jul 24, 2018
Modulators of development of adipocyte and cancer cells
HOPE CITY0 citations47
US9808434B2Nov 7, 2017
Compound for treating cancer and diabetes
HOPE CITY0 citations47
US9855233B2Jan 2, 2018
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG
HOPE CITY0 citations46